Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study

Area of Science:

• Immunology
• Neuroscience
• Genetics

Background:

• Peripheral immune system alterations are observed in amyotrophic lateral sclerosis (ALS).
• The precise causal link between immune changes and ALS pathogenesis remains debated.

Purpose of the Study:

• To investigate the causal relationship between peripheral immune markers and ALS.
• To leverage Mendelian randomization to assess immune system's role in ALS risk.

Main Methods:

• Employed a two-sample Mendelian randomization approach.
• Utilized genome-wide association study (GWAS) data for immune traits (exposure) and ALS (outcome).
• Applied inverse variance weighting, MR-Egger, and weighted median methods with sensitivity analyses.

Main Results:

• Increased lymphocyte count correlated with reduced ALS risk.
• Specific T cell populations (CD3+, HLA-DR+, effector memory, terminally differentiated, CD28-) were protective against ALS.
• Elevated α-2-macroglobulin receptor-associated protein (α-2-MRAP) and C4b were associated with lower ALS risk, while Interleukin-21 (IL-21) was linked to increased risk.

Conclusions:

• Peripheral immune activity plays a significant role in the development or progression of ALS.
• Identified specific immune markers with potential causal effects on ALS risk.